USE OF MISOPROSTOL IN ABORTION ON MEDICAL GROUNDS - OUR CLINICAL EXPERIENCE

被引:0
|
作者
Zhekov, Zhivko [1 ,2 ]
Radeva, Svetlana [1 ,3 ]
机构
[1] Specialized Hosp Obstet & Gynecol Act Treatment Va, Dept Gynecol, Varna, Bulgaria
[2] Med Univ Varna, Dept Obstet & Gynecol, 150 Tcar Osvoboditel Blvd, Varna 5000, Bulgaria
[3] Med Univ Varna, Fac Publ Hlth, Dept Hlth care, Varna, Bulgaria
来源
JOURNAL OF IMAB | 2024年 / 30卷 / 02期
关键词
malformations; prenatal diagnosis; Commission medical abortion; Misoprostol; therapeutic scheme; MIFEPRISTONE;
D O I
10.5272/jimab.2024302.5545
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose . In clinical practice in hospital conditions, the preferred choice of behavior regarding fetal anomalies is to perform a medical abortion after the opinion of a specialized committee in the hospital. There are no observations conducted by other authors on abortions related to termination of pregnancy for medical reasons at a different time. The team conducts its observation in hospital conditions. Material/Methods: Conducted own retrospective study for the period January 2021 - February 2024 with the participation of 45 patients who went through a pregnancy termination committee on medical grounds. All women who passed through the committee for medically indicated abortion, in which fetal anomalies incompatible with life or severely debilitating were found, were examined. Women are at different stages of pregnancy, age, education, number of pregnancies and births, concomitant diseases, a type of test to diagnose abnormalities in the fetus (invasive and non-invasive). The type of abnormality that is the cause of an abortion on medical grounds has also been investigated. The dosage applied is- 1st tablet of 400 mg Misoprostol per vagine, second and third tablets in 3 hours sub buccal, the maximum dose is 5 tablets in 24 hours or 2000 microgram Misoprostol. Results . For 88,9% of the cases, they have a positive opinion of the commission in the hospital structure, and 11,1% have a refusal. Group matching of patients was performed by education and whether they had good outpatient follow-up, regardless of the duration of pregnancy. Patients with higher education had better outpatient follow-up ( chi 2=15.497, p=0.000) than those with secondary and primary education. There was a significant association between the dosing regimen and pregnancy severity; the relationship between the two -dose regimen was significant ( chi 2=53.862, p=0.000), and the three -dose regimen was highly successful in 73.3% of cases. Conclusion. The correct choice of method of application of the therapeutic regimen requires preliminary and detailed medical preparation of the patient and good clinical experience of the treating doctor. The applied therapeutic approach reduces the risk to the patient and has a rapid recovery period. Early and timely diagnosis has an important informative value.
引用
收藏
页码:5545 / 5551
页数:7
相关论文
共 50 条
  • [1] Misoprostol use as a method of medical abortion
    Salakos, N.
    Iavazzo, C.
    Bakalianou, K.
    Gregoriou, O.
    Paltoglou, G.
    Kalmantis, K.
    Botsis, A.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2008, 35 (02): : 130 - 132
  • [2] Pilot study on the use of sublingual misoprostol for medical abortion
    Tang, OS
    Ho, PC
    CONTRACEPTION, 2001, 64 (05) : 315 - 317
  • [3] Acceptability of home-use of misoprostol in medical abortion
    Fiala, C
    Winikoff, B
    Helström, L
    Hellborg, M
    Gemzell-Danielsson, K
    CONTRACEPTION, 2004, 70 (05) : 387 - 392
  • [4] Medical abortion with mifepristone and misoprostol
    Xiao, B
    PROCEEDINGS OF THE XIX ASIAN AND OCEANIC CONGRESS OF OBSTETRICS & GYNECOLOGY, 2005, : 219 - 225
  • [5] MISOPROSTOL AND LEGAL MEDICAL ABORTION
    不详
    LANCET, 1991, 338 (8777): : 1241 - 1242
  • [6] Assessment of pain during medical abortion with home use of misoprostol
    Cavet, Sandra
    Fiala, Christian
    Scemama, Agathe
    Partouche, Henri
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2017, 22 (03): : 207 - 211
  • [7] Medical abortion with mifepristone and misoprostol: A clinical trial in Taiwanese women
    Tsai, EM
    Yang, CH
    Lee, JN
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (04) : 277 - 282
  • [8] Mifepristone-misoprostol medical abortion: Who will use it and why?
    Blinder, V
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (05) : 1376 - 1376
  • [9] Experience and acceptability of medical abortion with mifepristone and misoprostol among US women
    Beckman, LJ
    Harvey, SM
    WOMENS HEALTH ISSUES, 1997, 7 (04) : 253 - 262
  • [10] Misoprostol Use in Incomplete Abortion
    Maqsood, Fauzia
    Arif, Wasima
    Iqba, Saima
    Bajwa, Zafar Iqbal
    Ali, Muhammad
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2011, 17 (02): : 145 - 149